StockWatch
·
Pharmaceuticals
Board Meeting7 May 2026, 04:08 pm

Caplin Point Labs Board Meeting on May 14, 2026

AI Summary

Caplin Point Laboratories Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited financial results for the year ended March 31, 2026 (standalone & consolidated). The board will also consider the declaration of an interim dividend, if any, for FY 2025-26 and the fixation of a record date. The trading window for designated persons remains closed until May 16, 2026.

Key Highlights

  • Board meeting scheduled for May 14, 2026 to approve audited financial results.
  • Consideration of interim dividend for FY 2025-26 is on the agenda.
  • Record date for dividend eligibility will be determined at the meeting.
  • Trading window remains closed until May 16, 2026.